AstraZeneca (Paludrine, Avlocor, Savarine) Overview

  • Founded
  • 1998
  • Status
  • Acquired/​Merged
  • Employees
  • 7,352
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

AstraZeneca (Paludrine, Avlocor, Savarine) General Information


Provider of antimalarial medication brands. The company consists of three antimalarial brands, Paludrine, Avloclor, Savarine developed by AstraZeneca UK Limited.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Primary Office
  • 1 Francis Crick Avenue
  • Cambridge Biomedical Campus
  • Cambridge CB2 0AA
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AstraZeneca (Paludrine, Avlocor, Savarine) Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AstraZeneca (Paludrine, Avlocor, Savarine)‘s full profile, request access.

Request a free trial

AstraZeneca (Paludrine, Avlocor, Savarine) Executive Team (1)

Name Title Board Seat Contact Info
Peter Selley President & Chief Executive Officer
To view AstraZeneca (Paludrine, Avlocor, Savarine)’s complete executive team members history, request access »

AstraZeneca (Paludrine, Avlocor, Savarine) Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial